Communiqué from the Annual General Meeting of SelectImmune Pharma AB
On November 23, 2022, SelectImmune Pharma AB (publ) hekd its annual general meeting. A summary of the decisions made are listed below. All decisions were made unanimously.Determining the income statement and balance sheet as well as distribution of income The meeting decided to determine the income statement and balance sheet as included in the presented annual report. The meeting decided to dispose of the company's results according to the board's proposal in the annual report. Furthermore, it was decided that no dividend will be paid for the financial year 2021/2022.